‘Too good to be true’: Biotech company’s paper on Parkinson’s retracted for data manipulation

A Cell Press journal has retracted a paper on Parkinson’s disease following the discovery that the first author manipulated data in the work.

The retraction notice in Cell Reports states one of the coauthors found the first author, Madhuja Samaddar, changed data points to reduce variability and improve statistical significance in ways that affect some of the figures and conclusions.

The authors, all scientists at Denali Therapeutics in South San Francisco at the time of publication, studied how a buildup of molecules called polyamines interferes with an enzyme that breaks down fat, specifically in cell and mouse models of neurologic diseases like Parkinson’s. 

Continue reading ‘Too good to be true’: Biotech company’s paper on Parkinson’s retracted for data manipulation